Study Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma
Clinical trial NCT03979066 · TERMINATED
Trial details
- NCT number
- NCT03979066
- Sponsor
- Gulam Manji
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2019-11-03
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.